OBJECTIVE: Stereotactic radiosurgery has been used increasingly for the treatment of glomus jugulare tumors. The authors report their experience treating these tumors using gamma knife radiosurgery (GKRS), documenting the clinical and radiological outcome. METHODS: A retrospective analysis identified 17 patients with glomus jugulare tumors who underwent GKRS. Besides analysis of clinical outcome, a radiological volumetric analysis was also performed after treatment. RESULTS: There were 15 women and two men (average age, 63.1 yr) with a median follow-up period of 48 months. The median radiosurgical dose to the tumor margin was 15 Gy (range, 13-18 Gy). Eight patients (47.1%) improved clinically, two (11.8%) worsened, and seven (41.2%) were unchanged. No relationship between internal auditory canal dose and hearing loss was recorded. Tinnitus and otalgia were the symptoms that responded most favorably to GKRS. No patients experienced new lower cranial nerve palsies after GKRS. Tumor volume showed a transient increase in seven patients. Analysis of tumor volume at the time of the last magnetic resonance imaging scan recorded a decrease in eight patients, an increase in four patients, and no change in five patients. CONCLUSION: GKRS is a safe, effective treatment for glomus jugulare tumors, particularly in patients with preserved glossopharyngeal and vagus nerve function, after surgical recurrence, in the elderly, and in patients with serious preexisting medical conditions. Longer follow-up periods are required to assess long-term effects.
OBJECTIVE: Stereotactic radiosurgery has been used increasingly for the treatment of glomus jugulare tumors. The authors report their experience treating these tumors using gamma knife radiosurgery (GKRS), documenting the clinical and radiological outcome. METHODS: A retrospective analysis identified 17 patients with glomus jugulare tumors who underwent GKRS. Besides analysis of clinical outcome, a radiological volumetric analysis was also performed after treatment. RESULTS: There were 15 women and two men (average age, 63.1 yr) with a median follow-up period of 48 months. The median radiosurgical dose to the tumor margin was 15 Gy (range, 13-18 Gy). Eight patients (47.1%) improved clinically, two (11.8%) worsened, and seven (41.2%) were unchanged. No relationship between internal auditory canal dose and hearing loss was recorded. Tinnitus and otalgia were the symptoms that responded most favorably to GKRS. No patients experienced new lower cranial nerve palsies after GKRS. Tumor volume showed a transient increase in seven patients. Analysis of tumor volume at the time of the last magnetic resonance imaging scan recorded a decrease in eight patients, an increase in four patients, and no change in five patients. CONCLUSION: GKRS is a safe, effective treatment for glomus jugulare tumors, particularly in patients with preserved glossopharyngeal and vagus nerve function, after surgical recurrence, in the elderly, and in patients with serious preexisting medical conditions. Longer follow-up periods are required to assess long-term effects.
Authors: Zachary D Guss; Sachin Batra; Charles J Limb; Gordon Li; Michael E Sughrue; Kristin Redmond; Daniele Rigamonti; Andrew T Parsa; Steven Chang; Lawrence Kleinberg; Michael Lim Journal: Int J Radiat Oncol Biol Phys Date: 2011-06-22 Impact factor: 7.038
Authors: Julian Künzel; Johannes Zenk; Michael Koch; Joachim Hornung; Heinrich Iro Journal: Eur Arch Otorhinolaryngol Date: 2011-11-20 Impact factor: 2.503
Authors: Rawee Ruangkanchanasetr; John Y K Lee; Suneel N Nagda; Geoffrey A Geiger; James D Kolker; Douglas C Bigelow; Michael J Ruckenstein; MacLean Nasrallah; Michelle Alonso-Basanta Journal: J Neurol Surg B Skull Base Date: 2018-05-10
Authors: Victor Tse; Jussi Sillanpaa; Ann Y Minn; Ming Teng; Fu Xiaoyang; Amy Gillis; Laura Millender; William Sheridan; William Wara Journal: J Radiosurg SBRT Date: 2017
Authors: Anna Prajsnar; Naci Balak; Gerhard F Walter; Alexandru C Stan; Wolfgang Deinsberger; Leyla Tapul; Cicek Bayindir Journal: Surg Neurol Int Date: 2011-04-19